0001237899-11-000050.txt : 20110902
0001237899-11-000050.hdr.sgml : 20110902
20110902164525
ACCESSION NUMBER: 0001237899-11-000050
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110831
FILED AS OF DATE: 20110902
DATE AS OF CHANGE: 20110902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VAGELOS P ROY
CENTRAL INDEX KEY: 0001013064
STANDARD INDUSTRIAL CLASSIFICATION: AIRCRAFT [3721]
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 111074036
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0304
4
2011-08-31
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001013064
VAGELOS P ROY
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
1
0
0
Chairman of the Board
Common Stock
2011-08-31
4
M
0
312500
28.01
A
452587
D
Common Stock
2011-08-31
4
F
0
143587
60.96
D
309000
D
Common Stock
2011-08-31
4
F
0
76458
60.96
D
232542
D
Common Stock
2011-09-01
4
S
0
3500
60
D
229042
D
Common Stock
2011-09-02
4
S
0
35968
60.35
D
193074
D
Common Stock
2011-09-02
4
S
0
29529
61.42
D
163545
D
Common Stock
2011-09-02
4
S
0
23458
62.04
D
140087
D
Common Stock
2271
I
By 401(k) Plan
Common Stock
175056
I
by CLAT
Common Stock
94222
I
by GRAT
Common Stock
160000
I
by Spouse as Trustee
Common Stock
1203
I
by trust for grandch
Non-Qualified Stock Option (right to buy)
28.01
2011-08-31
4
M
0
312500
D
2002-12-18
2011-12-18
Common Stock
312500
0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 3,500 shares of Company stock on September 1, 2011 at prices ranging from $60.00 to $60.03. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 1, 2011 at each separate price.
Represents volume-weighted average price of sales of 35,698 shares of Company stock on September 2, 2011 at prices ranging from $60.00 to $60.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 2, 2011 at each separate price.
Represents volume-weighted average price of sales of 29,529 shares of Company stock on September 2, 2011 at prices ranging from $61.06 to $61.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 2, 2011 at each separate price.
Represents volume-weighted average price of sales of 23,458 shares of Company stock on September 2, 2011 at prices ranging from $62.01 to $62.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 2, 2011 at each separate price.
By an irrevocable trust for the benefit of grandchildren of the reporting person, of which the spouse of the reporting person is trustee.
By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case.
/s/**P. Roy Vagelos
2011-09-02